Dynamics of HCV viremia during early HCV infection: Implications for minipool (MP) vs individual donation (ID) nucleic acid amplification testing (NAT)

被引：0
|
作者：
Busch, MP
Giachetti, C
Conrad, A
Gallarda, J
Mimms, LT
Peddada, L
Charles, H
Raia, S
Fiebig, EW
Wright, D
机构：
[1] GenProbe Inc, San Diego, CA USA
[2] Blood Ctr Pacific, San Francisco, CA USA
[3] Roche Mol Syst Inc, Pleasanton, CA USA
[4] Alpha Therapeut, Los Angeles, CA USA
[5] BioClin Partners, Franklin, MA USA
[6] Univ Calif San Francisco, San Francisco Gen Hosp, Med Ctr, San Francisco, CA USA
[7] Westat Inc, San Luis Obispo, CA USA
[8] Natl Inst Genet, Los Angeles, CA USA
来源：
TRANSFUSION | 2000年 / 40卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：25S / 26S
页数：2
相关论文
共 30 条
  • [1] HBV viremia preceding HBsAG positivity: Implications for minipool (MP) and individual donation (ID) HBV nucleic acid testing (NAT)
    Peddada, L
    Heldebrant, C
    Smith, R
    Conrad, A
    Raia, S
    Wright, D
    Fiebig, EW
    Busch, MP
    TRANSFUSION, 2000, 40 (10) : 14S - 15S
  • [2] Early experience with individual donation nucleic acid amplification testing (ID-NAT) for HBV/HCV/HIV-1 in South Africa
    Sykes, W.
    Reddy, V.
    Vermeulen, M.
    Neill, A.
    Lelie, N.
    Mitchell, J.
    Pillay, L.
    TRANSFUSION, 2006, 46 (09) : 9A - 9A
  • [3] HIV viremia preceding antibody (Ab) seroconversion (SC): Detection by P24 antigen (AG), minipool nucleic acid amplification tests (MP-NAT) and individual donation (ID) NAT
    Fiebig, EW
    Heldebrant, C
    Smith, R
    Conrad, A
    Wright, D
    Kleinman, SH
    Busch, MP
    TRANSFUSION, 2000, 40 (10) : 25S - 25S
  • [4] HBV and HCV infected blood donations interdicted by individual donation nucleic acid testing (ID-NAT) in Lithuania
    Kalibatas, V.
    Irzikeviciene, J.
    Lelie, N.
    VOX SANGUINIS, 2006, 91 : 83 - 83
  • [5] Early experience with individual donation HBV/HCV/HIV-1 nucleic acid amplification testing (ID-NAT) in the South African National Blood Service
    Sykes, W.
    Vermeulen, M.
    Neill, A.
    Kuun, E.
    Lelie, N.
    Mitchell, J.
    Pillay, L.
    Reddy, V.
    VOX SANGUINIS, 2006, 91 : 87 - 88
  • [6] HCV and HBV infections interdicted by individual donation (ID)-NAT testing in Lithuania
    Kalibatas, V
    VOX SANGUINIS, 2008, 95 : 281 - 281
  • [7] Experience in nucleic acid amplification testing (NAT) for hepatitis C (HCV) in Canada
    Sher, GD
    Zuber, ED
    Scalia, V
    TRANSFUSION, 2000, 40 (10) : 89S - 89S
  • [8] Supplemental testing for HCV: To what extent could nucleic acid amplification testing (NAT) replace HCV RIBA 3.0?
    Valinsky, JE
    Bianco, C
    TRANSFUSION, 2000, 40 (10) : 32S - 32S
  • [9] HBV DNA detection in HBsAg EIA-negative (neg), anti-HBc-positive (pos) units: Implications for minipool (MP) and individual donation (ID) HBV nucleic acid testing (NAT)
    Kleinman, SH
    Kuhns, MC
    Busch, MP
    Todd, D
    McNamara, AL
    TRANSFUSION, 2001, 41 (09) : 7S - 7S
  • [10] Nucleic acid amplification testing (NAT) of midwestern blood donors for HCV RNA.
    Tegtmeier, GE
    Henderson, SE
    Blosser, JK
    TRANSFUSION, 1999, 39 (10) : 93S - 93S
123